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Background/Objectives: The certification process to register patients as sight impaired or 44 
severely sight impaired is undertaken by consultant ophthalmologists, in the UK.  We sought 45 
to assess the agreement between optometrists and a consensus panel, in identifying patient 46 
eligibility for certification, relative to the agreement between ophthalmologists and the 47 
consensus panel.   48 
 49 
Methods: The consensus panel (4 consultant ophthalmologists and 3 optometrists with a 50 
formal accreditation in low vision), 30 consultant ophthalmologists and 99 low vision 51 
optometrists reviewed 40 randomly-selected abridged cases.  The eligibility outcomes from 52 
the ophthalmologists and the optometrists were compared to the consensus panel 53 
outcomes. 54 
  55 
Results: For ophthalmologists and optometrists, the median (IQR) number of cases in which 56 
there was agreement with the consensus panel was 33.0 (31.0, 33.0) and 36.0 (34.0, 36.5), 57 
respectively.  In severely sight impaired cases, the probabilities of agreeing on eligibility for 58 
certification were 76.0% (95% CIs 71.4%, 80.1%) for ophthalmologists and 61.8% (59.0%, 59 
64.6%) for optometrists.  In sight impaired cases, the comparable figures were 51.6% 60 
(46.7%, 56.4%) for ophthalmologists and 72.2% (69.8%, 74.5%) for optometrists. In cases of 61 
bilateral atrophic age-related macular degeneration (AMD), both groups were more likely to 62 
agree with the consensus panel and the differences between optometrists and 63 




Conclusions: Optometrists demonstrated a comparable agreement relative to 66 
ophthalmologists, with the consensus panel on the eligibility of randomly-selected, abridged 67 
cases for certification.  The findings support the clinical decision-making ability of low vision 68 
optometrists in the certification of patients with vision impairment and provide evidence in 69 
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Patients who are eligible to be registered as sight impaired or severely sight impaired require a 91 
certificate of vision impairment to be completed by a consultant ophthalmologist, in the UK. This is 92 
undertaken with reference to the UK guidelines on certification.1  93 
 94 
Patients with a completed certificate of vision impairment can then choose to be registered with 95 
the local government social services department, which then allows access to services and support; 96 
although, such support can also be accessed without certification. A greater level of support is 97 
available to those registered as severely sight impaired compared to sight impaired. In England, the 98 
certificate of vision impairment is used to inform Government metrics of public health 99 
improvement and protection, 2 and in Wales, it is used to indicate incident certifiable sight 100 
impairment.3 101 
 102 
An additional role of the certificate of vision impairment is the collection of epidemiological 103 
information about the incidence and causes of certifiable sight loss in the UK 4, 5.  Whilst the 104 
number of certificates issued in the UK accurately reflects those registered with social 105 
services as having vision impairment 6, it does not represent all individuals living with sight 106 
loss.  Indeed, it is estimated that up to 51% of those eligible for certification are not 107 
certified7-9 and the incidence of certification varies across geographical locations 10.  From 108 
studies involving medical record review7, 8, 11 and patient interviews,9 it was found that 109 
those with a treatable condition or receiving ongoing treatment were more likely to be 110 
certified than those with untreatable conditions.  Additionally, those from ethnic minorities 111 
were less likely to be certified than Caucasian patients7, 9 and those with visual field loss 112 




There is a mismatch in demand and capacity for available secondary care ophthalmology 115 
appointments, and the long waiting times for appointments may put people at risk of 116 
irreversible sight loss 4. Given the care capacity issues, the role of the primary care 117 
optometrist has expanded, with the introduction and development of enhanced eye care 118 
services 12.  119 
 120 
In Wales, over 8,500 individuals with low vision are examined by the primary care-based 121 
Low Vision Service (LVSW) each year. Registration with vision impairment is not a 122 
prerequisite for access to this service. The LVSW is provided by 184 practitioners (171 123 
optometrists and 13 dispensing opticians) who have completed and continuously undergo 124 
specialist training.  125 
 126 
In order to assess the appropriateness of an expanded role of LVSW accredited optometrists 127 
in the certification of vision impairment, there is a need to evaluate their clinical ability in 128 
identifying the eligibility of a range of individuals for certification.  The aims of this study 129 
were to twofold.  Firstly, to assess the agreement between optometrists and a consensus 130 
panel, in identifying patient eligibility for certification, relative to the agreement between 131 
ophthalmologists and the consensus panel.  The second aim was to explore whether the 132 
agreement between clinician groups and the consensus panel was influenced by the 133 
presence of bilateral atrophic age-related macular degeneration (AMD) as the cause of 134 
vision impairment.  This is important given the potential to influence policy in Wales in the 135 
certification of patients with bilateral atrophic AMD by optometrists, as the clinical 136 




MATERIALS AND METHODS 139 
Case records from 40 individuals were selected at random (www.random.org), from 8,000 140 
patients seen by the LVSW between April 2017 and April 2018, stratified by the three 141 
categories of severity of sight loss  and anonymised.   The case records for each individual 142 
conformed to the following inclusion criteria: consent had been given to use the data for 143 
research and individuals were at least 18 years old.  144 
 145 
Details from each case record were transferred to a proforma and consisted of: age, gender, 146 
time since diagnosis, occupation, social and living situation, general health, the presence of 147 
a hearing impairment, problems reported, support received to date, diagnosis (right and left 148 
eye), refraction (distance and near), visual acuity (distance and near, monocular and 149 
binocular), binocular contrast sensitivity (measured using the Pelli-Robson chart, reported in 150 
terms of percentage loss and whether the loss was considered as: normal, noticeable loss, 151 
significant loss, severe loss 13) and the visual field status. Visual field printouts were included 152 
where available.  153 
 154 
The consensus panel consisted of four consultant ophthalmologists and three LVSW 155 
optometrists. Each consultant had been registered with the General Medical Council 156 
specialist register for ophthalmology for at least 2 years and had undergone the standard 157 
seven years of speciality training prior to this. Each of the LVSW optometrists had been 158 
registered with the General Optical Council in addition to specialising in low vision for at 159 
least 15 years and had each completed a Masters Level qualification in low vision. The 160 
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consensus panel met to determine the certification eligibility of each of the anonymised 161 
case records based on the information presented. In cases of disagreement on the 162 
certification outcome, the case was discussed until unanimous agreement was reached.  163 
 164 
An anonymous online survey was then created (https://www.onlinesurveys.ac.uk), in order 165 
to present each of the case records in a random order for each new respondent. All National 166 
Health Service consultant ophthalmologists practicing in Wales (n=58) and all LVSW 167 
optometrists (n=162) were invited to take part as raters in the online survey to evaluate the 168 
40 case records. Consultant ophthalmologists and LVSW optometrists who were in either 169 
the consensus panel and/or the research team were excluded from the survey. The survey 170 
was completed without time or other restrictions in an unsupervised environment. 171 
 172 
Raters were asked to decide on the certification eligibility status (not eligible, sight impaired 173 
[SI], or severely sight impaired [SSI]) of each of the 40 cases, with reference to the English 174 
guidelines (Department of Health 2013). These guidelines were provided at the start of the 175 
online survey, and were available to be viewed within each of the 40 cases. 176 
 177 
The survey was available for completion from the 23rd April 2018 until 3rd July 2018.  An 178 
incentive of 18 GBP was offered to optometrists to complete the survey. A pragmatic 179 
decision was taken not to offer the incentive to the ophthalmologists. It was advised by the 180 
ophthalmologists on the consensus panel that payment to the ophthalmologist participants 181 
would not have a significant effect on participation and the administrative process of 182 




Ethical approval was gained from the School of Optometry and Vision Sciences Research 185 
ethics and Audit committee (approval number 1443) at Cardiff University. Consent to take 186 
part in the study was obtained at the beginning of the online survey. The research was 187 
conducted according to the tenets of the Declaration of Helsinki. 188 
 189 
 190 
Analysis  191 
The agreement between each rater group and the consensus panel was determined using 192 
eligibility as both a trichotomous variable (not eligible, SI, SSI) and a dichotomous variable 193 
(not eligible or eligible, i.e. encompassing both SI and SSI).   194 
 195 
Modelling was then undertaken using the outcome: exact agreement with panel/disagree 196 
with panel. Given the 129 ratings for each case, i.e., one rating from each ophthalmologist 197 
and optometrist, we used a multilevel model in which inter rater variability was quantified 198 
using a random effect. Initially, the variable, agreement (exact agreement with 199 
panel/disagree with panel), was modelled as an outcome in a logistic regression on rater 200 
group (ophthalmologist/optometrist), consensus panel eligibility rating, and an interaction 201 
term between the two. Additionally, bilateral atrophic AMD was then included as another 202 
variable in the modelling. 203 
 204 
Krippe dorf’s alpha was used to calculate inter-rater agreement within each clinician group 205 




All analyses were conducted in R Version 3.5.1 and mixed effects models were fitted using 208 






The demographic and clinical details of each of the 40 cases are shown in Table S1 (online 215 
only supplementary table) and in Figures 1a and 1b. Primary causes of vision loss in the 40 216 
case records included: cataract, neovascular and atrophic AMD, Stargardts disease, cone 217 
dystrophy, diabetic eye disease, glaucoma, optic neuritis, nystagmus, retinal detachment, 218 
homonymous hemianopia resulting from stroke and retinitis pigmentosa. 219 
 220 
Of the 40 cases, the consensus panel agreed that 12 were not eligible for certification, 15 221 
were eligible to be certified as SI, and 13 certified as SSI (Table 1). There were no cases in 222 
which a group agreement by the consensus panel was not reached.   223 
 224 
Survey responses from 30 consultant ophthalmologists and 99 low vision optometrists were 225 
received, accounting for 52% and 61% of those eligible to take part (i.e. the total number of 226 
clinicians in Wales) from each rater group, respectively.   227 
 228 
Each of the 40 cases therefore was rated by 129 clinicians, giving a total of 5,160 ratings. 229 
Ophthalmologists produced 1,200 ratings; optometrists, 3,960 (Table 2).  These were not 230 
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independent observations: each of the 129 raters classified the same 40 cases. The 28 cases 231 
rated as eligible for certification by the panel thus provided 28 x 30 = 840 observations by 232 
ophthalmologists and 28 x 99 = 2,772 observations by optometrists. Seventy-five % (n=631) 233 
of the ophthal ologists’ rati gs of those ases ere eligi le for ertifi atio .  Eighty-eight % 234 
(n=2,440) ere eligi le i  the opto etrists’ ie  Ta le . 235 
 236 
For each rater, a count was made of the number of cases classified to each category. 237 
Ophthalmologists rated a median of 11 (IQR 9.25, 11) cases as SI and 10 (9.25, 10) as SSI. 238 
Optometrists rated a median of 17 (15, 19) cases as SI and 8 (7, 11) as SSI. 239 
 240 
Compared to the consensus panel who considered 12 of the cases to be ineligible, a median 241 
of 19 (IQR 18.25, 20) cases were rated ineligible by ophthalmologists and 14 (12, 16) by 242 
optometrists. Fifteen cases were rated as SI by the consensus panel, whilst 11 (9.25, 11) and 243 
17 (15, 19) cases were rated as SI by the ophthalmologists and optometrists, respectively.  244 
Thirteen cases were rated as SSI by the consensus panel, whilst 10 (9.25, 10) and 8 (7, 11) 245 
cases were rated as SSI by ophthalmologists and optometrists, respectively. This, however, 246 
does not indicate the level of agreement concerning individual cases. We then determined, 247 
for each case and rater, hether the rater agreed ith the o se sus pa el’s outcome, 248 
either when considering the dichotomous (eligible/not eligible) rating or the trichotomous 249 
(not eligible/SI/SSI) rating. 250 
 251 
The agreement between each rater group with the consensus panel is shown in Figure 1c. 252 
Figure 1d is an alternative presentation of the same data. For the dichotomous rating, the 253 
opto etrists’ distri utio  is learly differe t to the ophthal ologists’ a d i  etter a ord 254 
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ith the o se sus pa el’s outcome. For ophthalmologists, the median (IQR) number of 255 
cases in which there was agreement with the consensus panel was 33.0 (31.0, 33.0); 256 
comparable figures for optometrists were 36.0 (34.0, 36.5). For ophthalmologists, the mode 257 
was 33, where 13 ophthalmologists (43%) agreed with the consensus panel. Similarly, for 258 
optometrists, the mode was 36 cases, where 26 optometrists (26%) agreed with the 259 
consensus panel. For the trichotomous rating, the median (IQR) number of cases in which 260 
there was full agreement with the consensus panel was 30.0 (28.3, 30.0); comparable 261 
figures for optometrists were 30.0 (27.0, 31.5).    262 
 263 
Table 3 (charted in Figure 2a) shows the probability of rating the eligibility of the cases in 264 
exact agreement with the consensus panel, for each rater group, together with 95% 265 
confidence intervals derived from the fitted model. The greatest differences between 266 
optometrists and ophthalmologists occurred for cases determined by the consensus panel 267 
as SI: optometrists considered 72% of those cases as SI while ophthalmologists rated only 268 
52% as SI (95% CIs 0.70, 0.75 cf. 0.47, 0.56). For cases rated as SSI by the consensus panel, 269 
optometrists and ophthalmologists considered 62% and 76% as SSI, respectively (95% CIs 270 
0.59, 0.65 cf. 0.71, 0.80).  Agreement on cases that were, according to the consensus panel, 271 
not eligible, was closer between clinician groups.   272 
 273 
Bilateral atrophic AMD was then added in to the model as an explanatory variable (Figure 274 
2a, bottom panel), which was selected for inclusion given its clinical significance.  Overall, 275 
both clinician groups were more likely to agree with the consensus panel outcomes for 276 
cases of bilateral atrophic AMD than for cases in which it was not present. As previously, the 277 
greatest differences between optometrists and ophthalmologists occurred for cases eligible 278 
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for certification as SI; however, these differences were less marked in cases of bilateral 279 
atrophic AMD.  280 
 281 
As Figure 2b (top panel) suggests both ophthalmologists and optometrists largely agreed 282 
that those cases considered not eligible by the consensus panel were truly ineligible and 283 
that the cases considered SSI by the panel were eligible. Figure 2b (top panel) shows that for 284 
both groups, the classification of most cases was unambiguous: 19 of the cases were judged 285 
as eligible by over 90% of the optometrists, while a further 6 of the cases were considered 286 
eligible by less than 10% of the optometrists, i.e., over 90% of the optometrists considered 287 
those 6 to be ineligible. Ophthalmologists demonstrated a similar pattern with near 288 
unanimity over the classification of 16 cases as eligible and 12 cases were considered 289 
eligible by less than 10% of the ophthalmologists. For the cases determined as SI by the 290 
consensus panel (Figure 2b, bottom panel), there were 7 cases in which less than 50% of 291 
ophthalmologists agreed with the consensus panel, but only 2 cases in which same was true 292 
for optometrists. 293 
 294 
 295 
There were 11 cases of complete agreement amongst all the ophthalmologists and 296 
optometrists, one of which all considered ineligible, the others being eligible.  297 
 298 
Moderate to substantial inter-rater agreement was demonstrated within each rater group. 299 
Based on all 40 cases, for ophthal ologists, Krippe dorf’s alpha alues ere .  9 % CI 300 
0.62 – 0.81) and 0.8 (0.70 – 0.88), for the dichotomous and trichotomous classifications, 301 
respectively.  Similarly, the corresponding values for optometrists were 0.67 (0.53 –0.78) 302 





DISCUSSION  306 
This study evaluated the clinical decision-making abilities of low vision optometrists and 307 
consultant ophthalmologists in certifying patients as vision impaired.  Unlike the 308 
ophthalmologists, the optometrists were inexperienced in the process of certification 309 
However, low vision optometrists are experienced in managing patients with low vision and 310 
thus have a theoretical understanding of the certification of vision impairment, but not a 311 
current role in the formal certification process.  312 
 313 
The key finding of this study was that optometrists demonstrated comparable agreement 314 
relative to ophthalmologists, with the consensus panel outcomes on the eligibility of cases 315 
for certification. The similarity in performance between groups is demonstrated by the 316 
number of cases in which there was agreement with the consensus panel and the overall 317 
probability of rating the eligibility of cases in exact agreement with the consensus panel. For 318 
cases rated as SI, the probability of agreement with the consensus panel was greater for 319 
optometrists than for ophthalmologists, whilst the opposite was true for cases rated as SSI. 320 
Both clinician groups rated fewer cases as eligible relative to the consensus panel.  321 
Ophthalmologists were least likely to agree with the consensus panel outcome for cases 322 
judged by the consensus panel as SI, whilst optometrists were least likely to agree with the 323 
consensus panel for SSI cases. Whilst the results for SSI cases may reflect the naivety of the 324 
optometrists in the certification process, and may be partly explained by a stronger 325 
adherence to the clinical guidelines, the overall similarity between groups supports their 326 




In one case (case 3), classified as SI by the consensus panel, interestingly, 90% of the 329 
ophthalmologists classified this case as not eligible (Figure 2b).  Although this individual had 330 
better visual acuities than the guideline criteria for certification, she had a severe loss of 331 
contrast sensitivity, recent diagnosis of AMD, and lived alone.  This suggests the rating of 332 
the consensus panel may have allocated more weighting to the circumstantial factors than 333 
the visual acuity status, relative to that of the ophthalmologists.  Whilst contrast sensitivity 334 
is not specifically mentioned in the certification guidelines, clinicians may differ in their 335 
consideration of this outcome when it is available. However, decisions are never made on 336 
this outcome alone. 337 
 338 
Both clinician groups were more likely to agree with the consensus panel across all eligibility 339 
classifications in cases of bilateral atrophic AMD, relative to the other causes of vision 340 
impairment. In these cases, the differences between clinician groups was less, relative to 341 
those cases in which there was another cause of vision impairment i.e. not atrophic AMD.  342 
This difference was most marked for the SI cases (Figure 2a).  343 
 344 
AMD is the leading cause of certifiable vision impairment in England and Wales accounting 345 
for 50% of all certifications of vision impairment 16 and of these cases, atrophic AMD is the 346 
leading cause of vision loss in approximately 50% 17. Given the lack of clinical therapeutic 347 
options for atrophic AMD, patients with this condition would not be routinely monitored 348 
within the hospital eye service. Yet, the vision loss associated with severe atrophic AMD 349 
meets the threshold for eligibility for certification. Therefore, these patients would 350 
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particularly benefit from access to certification through primary care optometry, should it 351 
become available.   352 
 353 
This is the first study to measure the agreement between optometrists and consultant 354 
ophthalmologists in the consideration of eligibility for certification of patients with vision 355 
impairment. Previous studies have examined the agreement between optometrists and 356 
ophthalmologists, in other clinical tasks 18-23.  Some have shown moderate to substantial 357 
agreement between these groups in the grading of anterior chamber angles 19 and in the 358 
evaluation of glaucoma 20-23.  Others have demonstrated poor levels of agreement between 359 
and within consultant ophthalmologists, in classifying patients with glaucomatous visual 360 
field defects 18.  However, such comparisons to the present study are limited given the 361 
different nature of these clinical tasks.  362 
 363 
The strengths of the study include the substantial proportion of clinicians relative to the 364 
overall workforce in Wales who took part in the study.  A consensus panel was adopted to 365 
provide a reference standard for clinical decision-making.  366 
 367 
The limitations of the study include the online delivery of the survey, which may have 368 
resulted in the self-selection of clinicians with a specific interest to act as participants.  A 369 
moderate number of anonymised cases were reviewed, although they were representative 370 
of the variety of disease types and individual circumstances of such cases. The grading of 371 
anonymised cases does not fully simulate the interaction that occurs between a clinician 372 
and a patient.  Additionally, whilst the ophthalmologists were experienced in the real life 373 
process of certification, neither of the clinician groups were familiar with the task of 374 
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classifying abridged cases.  A possible risk of bias could be attributed to the incentivisation 375 
to optometrists but not ophthalmologists, however, the payment was offered 376 
independently of performance in the classification task, and therefore should be expected 377 
to be independent of the recorded outcomes for each participant.   378 
 379 
The number of optometrist participants was consistent with the number who claimed the 380 
incentive.  Although the possibility that an ophthalmologist participant completed the 381 
survey more than once cannot be excluded, it is unlikely, given the time taken to review 382 
each case, which was presented in a random order in each survey.   383 
 384 
Overall, the performance of optometrists was comparable to that of ophthalmologists in the 385 
rating of eligibility of virtual patient cases for the certification of vision impairment.  The 386 
findings support the clinical decision-making ability of low vision optometrists in the 387 
certification of patients with vision impairment, especially in cases of atrophic AMD.  A 388 
prospective study comparing the assessment of patients with bilateral atrophic AMD by low 389 
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FIGURE LEGENDS 489 
 490 
Figure 1 (a) The percentage of cases by gender and consensus panel outcome, according to 491 
demographic and clinical characteristics.  (b) The consensus panel outcome with respect to 492 
visual acuity and time since diagnosis.   (c) The number of cases out of 40 in which 493 
ophthalmologists (left) and optometrists (right) agreed with the consensus panel in the 494 
assessment of eligibility for certification as a dichotomous variable (not eligible or eligible; 495 
top) and as a trichotomous variable (bottom). (d) The distributions of the number of cases 496 
out of 40 in which ophthalmologists and optometrists agreed with the consensus panel in 497 
the assessment of eligibility for certification as a dichotomous variable (not eligible or 498 
eligible; left panel) and a trichotomous variable (not eligible, sight impaired, or severely 499 
sight impaired; right panel). Boxplot limits in (b) and (d) indicate the lower sample quartile, 500 
sample median and upper sample quartile. 501 
 502 
Figure 2. (a) The probability of agreeing with the consensus panel outcome, for each rater 503 
group.  The vertical grey bars represent the 95% confidence intervals.  The top panel in (a) 504 
shows the overall agreement and the bottom panel shows the agreement for cases in which 505 
the primary cause of vision impairment was (right) and was not (left) bilateral atrophic 506 
AMD.  (b) Distribution of cases by percentage of raters judging the cases to be eligible. The 507 
top panel shows the overall distribution.  The bottom panel shows the distribution for cases 508 










  Consensus panel outcome 





 Number of cases 
Total  12 15 13 
Case characteristic:     
Sex     
 Male 5 5 7 
 Female 7 10 6 
     
Age-related macular 
degeneration 




 3 4 5 
Lives alone  1 10 7 
Hearing impaired  1 4 2 
    Median(IQR) 
Age  78.5 (73.8, 86.0) 79.0 (71.5, 81.0) 79.0 (73.0, 81.0) 
Binocular distance visual 
acuity (LogMAR) 
 0.44 (0.30, 0.70) 0.90 (0.84, 1.00) 1.30 (1.00, 1.30) 
Years since diagnosis  6 (4, 10)  , . † .  , . †† 
† ased o   ases†† ased o   due to missing data 517 






  Consensus panel outcome 




impaired (SSI) Rater group Rater group’s 
classification 
Ophthalmologists     
 Not eligible 339 183 26 
 Sight impaired (SI) 19 232 68 
 Severely sight 
impaired (SSI) 
2 35 296 
Optometrists     
 Not eligible 1042 328 4 
 Sight impaired (SI) 138 1071 488 
 Severely sight 
impaired (SSI) 
8 86 795 
Table 2. Number of ratings by trichotomous classification of cases by the consensus panel 522 



















Rater group Consensus 
panel 
outcome  
Probability of rater group 
agreeing exactly with 
consensus panel 
Lower limit Upper limit 
Ophthalmologists Not eligible 0.942 0.913 0.962 
Optometrists Not eligible 0.878 0.858 0.896 
Ophthalmologists SI  0.516 0.467 0.564 
Optometrists SI  0.722 0.698 0.745 
Ophthalmologists SSI  0.760 0.714 0.801 
Optometrists SSI  0.618 0.590 0.646 
Table 3. Modelling outcomes showing the estimated probability of rating the eligibility of the 536 
cases in exact agreement with the consensus panel, for each rater group, with 95% 537 








ONLINE ONLY SUPPLEMENTARY MATERIAL 546 
Table S1. Demographic and clinical details for the 40 cases, including; age (years), sex 547 
(M=male, F=Female), time since diagnosis, whether the patient lives alone, whether there is 548 
a patient reported hearing impairment, eye condition (NAMD= neovascular AMD, GA= 549 
atrophic AMD, DR= diabetic retinopathy, DM= diabetic maculopathy), severity of binocular 550 
contrast sensitivity loss [13] measured with Pelli-Robson chart, monocular and binocular 551 
distance visual acuity (LogMAR), binocular near visual acuity, visual field status (as recorded 552 
in original case record or as indicated by visual field printout), and consensus panel eligibility 553 
criteria (NE=not eligible, SI= Sight Impaired, SSI= Severely Sight Impaired). Cases of bilateral 554 
atrophic AMD are indicated by the term GA in both right eye (OD) and left eye (OS) columns. 555 
 556 
 557 
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